2020
DOI: 10.1007/s00405-020-06247-6
|View full text |Cite|
|
Sign up to set email alerts
|

Use of PerClot® in head and neck surgery: a Scottish centre experience

Abstract: Objective PerClot® is a biocompatible, polysaccharide haemostatic system recommended for surgical procedures. It is an absorbable modified polymer that is non-pyrogenic and is derived from purified plant starch. Our goal was to evaluate the safety, efficacy and usefulness of PerClot® in head and neck surgery (H&N) in our department. Methods All patients who received PerClot® after their neck operation over 1-year period (2019–2020) were prospec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Presently, a wide range of organic and inorganic substances have been the focus of thorough investigation, leading to the creation of coagulation-promoting powders. , Inorganic hemostatic powders, such as mesoporous silica, bioactive glass, kaolinite nanoclay, and calcium carbonate microspheres, have been demonstrated to be successful in managing bleeding by virtue of their vesicular structure and incorporation of inorganic metal oxides. , Organic hemostatic materials, including chitosan, starch, cellulose, gelation, and hyaluronic acid, have been thoroughly researched for their ability to effectively control hemorrhage . Some of these materials, such as chitosan-based Celox and starch-based PerClot, have even entered the commercial market. , In general, traditional hemostatic powders achieve hemostasis through three main mechanisms: (i) absorbing plasma to concentrate erythrocytes and thrombocytes, (ii) interacting and bonding with coagulation factors to initiate the coagulation cascade, and (iii) supporting the aggregation of blood components to form a physical seal on bleeding wounds. , However, there is no interaction between the hemostatic particles, resulting in a weak mechanical strength of the supported thrombus. Additionally, this traditional powder has poor tissue adhesion.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Presently, a wide range of organic and inorganic substances have been the focus of thorough investigation, leading to the creation of coagulation-promoting powders. , Inorganic hemostatic powders, such as mesoporous silica, bioactive glass, kaolinite nanoclay, and calcium carbonate microspheres, have been demonstrated to be successful in managing bleeding by virtue of their vesicular structure and incorporation of inorganic metal oxides. , Organic hemostatic materials, including chitosan, starch, cellulose, gelation, and hyaluronic acid, have been thoroughly researched for their ability to effectively control hemorrhage . Some of these materials, such as chitosan-based Celox and starch-based PerClot, have even entered the commercial market. , In general, traditional hemostatic powders achieve hemostasis through three main mechanisms: (i) absorbing plasma to concentrate erythrocytes and thrombocytes, (ii) interacting and bonding with coagulation factors to initiate the coagulation cascade, and (iii) supporting the aggregation of blood components to form a physical seal on bleeding wounds. , However, there is no interaction between the hemostatic particles, resulting in a weak mechanical strength of the supported thrombus. Additionally, this traditional powder has poor tissue adhesion.…”
Section: Introductionmentioning
confidence: 99%
“…17 Some of these materials, such as chitosan-based Celox and starch-based PerClot, have even entered the commercial market. 18,19 In general, traditional hemostatic powders achieve hemostasis through three main mechanisms: (i) absorbing plasma to concentrate erythrocytes and thrombocytes, (ii) interacting and bonding with coagulation factors to initiate the coagulation cascade, and (iii) supporting the aggregation of blood components to form a physical seal on bleeding wounds. 1,20 However, there is no interaction between the hemostatic particles, resulting in a weak mechanical strength of the supported thrombus.…”
Section: ■ Introductionmentioning
confidence: 99%
“…Some active agents, including brinogen and thrombin, actively participate at the end of the coagulation cascade to form brin clots (6) (7) (8). Others, such as porcine gelatin (9), oxidized cellulose (10), and plant-derived polysaccharide spheres (11) (12), are known as mechanical hemostats. They activate and aggregate platelets and form a matrix at the site of bleeding, allowing clotting to occur (8).…”
Section: Introductionmentioning
confidence: 99%